Platform Technologies
Our R&D capabilities are on par with global standards
Celltrion Pharm always looks for ways to make better pharmaceutical products
Overview
Celltrion Pharm ceaselessly carries out R&D projects to improve patients’ compliance with our medicine. These projects have resulted in various patented platform technologies, which have been acknowledged for their high technological achievements by experts across the world.
The DMB technology maximizes the moisture-proofing of pharmaceutical products by the dual action of moisture prevention. This formulation coating technology enhances the moisture stability of highly hygroscopic products vulnerable to moisture. With DMB technology, we can develop formulations with outstanding properties and physicochemical stability.
"TSR is a sustained release technology that combines three properties: ionic character, swelling, and hydrophobicity. These three different mechanisms work together to achieve excellent sustained release with small amounts of excipients. Moreover, TSR allows for reducing the size of pharmaceutical products.
"
Multilayer technology helps us secure the stability of compound ingredients and achieve double or higher release patterns by differentiating release rates across different layers. We apply this technology to most compound formulations in development to achieve outstanding stability and drug release patterns.